MALAT-1 (metastasis-associated lung adenocarcinoma transcript 1 also called NEAT2 or nuclear enriched abundant transcript 2) was first identified in NSCLC as a predictive marker associated with metastatic disease and shorter survival in early stage lung adenocarcinoma [98]. Here, MALAT1 is linked to metastatic neoplasm.